You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

telomerase inhibitor

Showing 1 - 25 of 7,439
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Telomere Shortening, Aging, Vascular Diseases Trial (TA-65, Placebo)

Not yet recruiting
  • Telomere Shortening
  • +2 more
  • TA-65
  • Placebo
  • (no location specified)
Oct 24, 2022

NSCLC Trial in Buderim, Adelaide (6-Thio-2'-Deoxyguanosine, Cemiplimab)

Recruiting
  • Carcinoma, Non-Small-Cell Lung
  • Buderim, Queensland, Australia
  • +1 more
Jul 5, 2022

Aging Trial (Pomegranate extract, Control)

Not yet recruiting
  • Aging
  • Pomegranate extract
  • Control
  • (no location specified)
Oct 18, 2022

Esophageal Cancer Trial in Hat yai (BKM120)

Terminated
  • Esophageal Cancer
  • Hat yai, Songkhla, Thailand
    Songklanagarind Hospital, Prince of Songkla University
Oct 3, 2021

Chronic Leukemia Trial in France (Additional biological samples)

Active, not recruiting
  • Chronic Leukemia
  • Additional biological samples
  • Besançon, France
  • +3 more
May 31, 2022

Oxidative Stress and Mitochondrial TERT in Papillary Thyroid

Recruiting
  • Papillary Thyroid Cancer
    • Milan, Italy
      Istituto Auxologico Italiano
    Mar 2, 2023

    Aging Trial in Padova (Monarda Didyma extract, Placebo)

    Not yet recruiting
    • Aging
    • Monarda Didyma extract
    • Placebo
    • Padova, PD, Italy
      Azienda Ospedale Università Padova
    Nov 2, 2022

    HIV Trial in Baltimore (Switch to Maraviroc + Raltegravir or Dolutegravir)

    Completed
    Has Results
    • HIV
    • Switch to Maraviroc + Raltegravir or Dolutegravir
    • Baltimore, Maryland
      University of Maryland, Institute of Human Virology
    Oct 5, 2021

    Circulating Tumor Cells In NSCLC Undergoing Definitive

    Active, not recruiting
    • Non-small Cell Lung Cancer
    • Radiotherapy
    • Philadelphia, Pennsylvania
      Abramson Cancer Center of the University of Pennsylvania
    Mar 31, 2022

    Heart Failure, Dilated Cardiomyopathy Trial in Shanghai (JV001)

    Recruiting
    • Heart Failure
    • Dilated Cardiomyopathy
    • JV001
    • Shanghai, Shanghai, China
      Shanghai East Hospital
    Apr 19, 2023

    Hepatocellular Carcinoma Trial in Seoul (RZ-001 Dose 1, RZ-001 Dose 2, RZ-001 Dose 3)

    Recruiting
    • Hepatocellular Carcinoma
    • RZ-001 Dose 1
    • +3 more
    • Seoul, Korea, Republic of
      Samsung Medical Center
    Oct 25, 2022

    Glioblastoma Trial in France (UCPVax, Temozolomide)

    Recruiting
    • Glioblastoma
    • Besançon, France
    • +3 more
    May 19, 2022

    Squamous Cell Carcinoma of the Head and Neck, Anal Canal Cancer, Cervical Cancer Trial in France (biological, procedure, other,

    Recruiting
    • Squamous Cell Carcinoma of the Head and Neck
    • +2 more
    • Blood sample collection
    • +4 more
    • Besançon, France
    • +4 more
    Nov 17, 2022

    Cancer, Cancer, Lung, Cancer of Lung Trial in Worldwide (UV1 vaccine + leukine, ipilimumab, nivolumab)

    Active, not recruiting
    • Cancer
    • +6 more
    • UV1 vaccine + leukine
    • +2 more
    • Perth, Australia
    • +6 more
    Jan 23, 2023

    Aging Trial in Bologna (Coenzyme Q10, Selenium, Resveratrol)

    Not yet recruiting
    • Aging
    • Coenzyme Q10
    • +5 more
    • (no location specified)
    Aug 12, 2022

    Glioblastoma Trial in United States (biological, radiation, drug)

    Active, not recruiting
    • Glioblastoma
    • INO-5401
    • +4 more
    • Duarte, California
    • +20 more
    Aug 8, 2022

    Ovarian Reserve Trial in Madrid (Danazol/Placebo, Without intervention)

    Completed
    • Ovarian Reserve
    • Danazol/Placebo
    • Without intervention
    • Madrid, Spain
      Ivirma Madrid
    Aug 9, 2022

    Neuroblastoma Trial in Montreal (Imetelstat)

    Withdrawn
    • Neuroblastoma
    • Montreal, Quebec, Canada
      CHU Sainte-Justine
    Sep 17, 2020

    Peripheral T Cell Lymphoma Trial in Beijing (Linperlisib in combined with Chidamide)

    Recruiting
    • Peripheral T Cell Lymphoma
    • Linperlisib in combined with Chidamide
    • Beijing, Beijing/China, China
    • +1 more
    Oct 9, 2023

    HIV-1-infection Trial in London (Doravirine, Dolutegravir, Triple cART regimen)

    Not yet recruiting
    • HIV-1-infection
    • London, United Kingdom
      Chelsea & Westminster Hospital NHS Foundation Trust
    Jun 23, 2021

    Cutaneous T-cell Lymphoma Trial in Beijing (Linperlisib in combined with Chidamide)

    Recruiting
    • Cutaneous T-cell Lymphoma
    • Linperlisib in combined with Chidamide
    • Beijing, Beijing, China
      Peking Union Medical College Hospital
    Sep 8, 2023

    Metastatic NSCLC Trial in France (UCPVax)

    Active, not recruiting
    • Metastatic Non-small Cell Lung Cancer
    • Besancon, France
    • +4 more
    Sep 22, 2022

    Schizophrenia, Physical Activity, Telomere Shortening Trial in Salamanca (Strength physical exercise programme, Normal life)

    Not yet recruiting
    • Schizophrenia
    • +3 more
    • Strength physical exercise programme
    • Normal life
    • Salamanca, Castilla Y León / Salamanca, Spain
      Universidad de Salamanca
    Aug 4, 2023

    Cervical Cancer Trial in Amsterdam (Anti-PD-1 antibody balstilimab)

    Not yet recruiting
    • Cervical Cancer
    • Anti-PD-1 antibody balstilimab
    • Amsterdam, Netherlands
      Amsterdam UMC
    Oct 17, 2023

    Hepatocellular Carcinoma (HCC) Trial in Taiwan (Chidamide, Regorafenib)

    Recruiting
    • Hepatocellular Carcinoma (HCC)
    • Kaohsiung, Taiwan
    • +4 more
    Mar 14, 2023